The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer

BMC Cancer

Table 4 Comparison of the diagnostic performance of several inflammation-based prognostic indices in predicting mortality

Indices	One year follow-up		Three years follow-up		Five years follow-up
	AUC(95% CI)	P	AUC(95% CI)	P	AUC(95% CI)	p
CRP/Alb	0.692(0.623–0.755)	<0.001	0.659(0.589–0.724)	<0.001	0.682(0.613–0.746)	<0.001
GPS	0.594(0.523–0.663)	0.054	0.579(0.508–0.649)	0.030	0.606(0.535–0.674)	0.040
mGPS	0.596(0.525–0.665)	0.049	0.573(0.502–0.643)	0.046	0.605(0.534–0.673)	0.043
NLR	0.613(0.542–0.681)	0.026	0.567(0.496–0.637)	0.078	0.601(0.530–0.670)	0.089
PNI	0.658(0.588–0.723)	0.002	0.637(0.566–0.704)	<0.001	0.631(0.560–0.698)	0.016
PLR	0.609(0.538–0.677)	0.028	0.595(0.524–0.664)	0.018	0.646(0.575–0.712)	0.007
PI	0.612(0.541–0.680)	0.022	0.569(0.497–0.638)	0.062	0.594(0.522–0.662)	0.063

Comparisons between AUCs at one year: CRP/Alb vs. GPS: p = 0.0003; CRP/Alb vs. mGPS: p = 0.0004. CRP/Alb vs. PI: p = 0.0087
Comparisons between AUCs at three year: CRP/Alb vs. GPS: p = 0.0002; CRP/Alb vs. mGPS: p < 0.0001. CRP/Alb vs. PI: p = 0.0001
CRP/Alb vs. NLR: p = 0.0166
AUC area under the curve, CRP/Alb C-reactive protein/albumin, GPS Glasgow Prognostic Score, mGPS modified GPS, NLR neutrophil to lymphocyte ratio, PLR Platelet lymphocyte ratio, PI Prognostic index, PNI Prognostic Nutritional Index

ISSN: 1471-2407